Jan Bewersdorf, MD

Articles by Jan Bewersdorf, MD

Phase I Study Investigates Combination of Ruxolitinib plus Abemaciclib in Myelofibrosis

Leah SherwoodMyelofibrosis | February 8, 2024

Jan Bewersdorf, MD, discusses a current ongoing phase I study investigating the combination of ruxolitinib and abemaciclib.